Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Toledo Pons (Palma De Mallorca, Spain), J. Van Boven (Groningen, Netherlands), J. Muncunill Farreny (Palma, Spain), A. Millán Pons (Palma, Spain), M. Román Rodríguez (Palma, Spain), B. López Andrade (Palma, Spain), J. Kocks (Groninegen, Netherlands), B. García-Cosío Piqueras (Palma, Spain). Impact of the eosinophil variability on severe exacerbations in an asthmatic population. 5044

Member's Comments

No comment yet.

Related content which might interest you: Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005 Role of neutrophils in maintenance of severity of non-allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Assessment of airway neutrophil activation in adult non-eosinophilic asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 The effect of bronchiectasis on asthma exacerbations Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Effect of aerobic training on airway inflammation and asthma symptoms in asthmatic patients Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009